Menu Search
Equities

Kringle Pharma Inc

4884:TYO

Kringle Pharma Inc

Actions
  • Price (JPY)902.00
  • Today's Change57.00 / 6.75%
  • Shares traded227.60k
  • 1 Year change+16.39%
  • Beta1.0559
Data delayed at least 20 minutes, as of Nov 25 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Kringle Pharma Inc grew revenues 15.58% from 69.25m to 80.04m while net income improved from a loss of 854.15m to a smaller loss of 756.45m.
Gross margin--
Net profit margin-945.12%
Operating margin-1,021.87%
Return on assets-28.14%
Return on equity-36.63%
Return on investment-30.03%
More ▼

Cash flow in JPYView more

In 2024, Kringle Pharma Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 838.23m or 1,047.29% of revenues. In addition the company used 661.17m for operations while cash used for investing totalled 121.36m.
Cash flow per share-82.31
Price/Cash flow per share--
Book value per share309.55
Tangible book value per share309.55
More ▼

Balance sheet in JPYView more

Kringle Pharma Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio21.50
Quick ratio19.20
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.